Plus Therapeutics Inc (PSTV) Aksiya narxi va yangiliklar

Bosh sahifaPSTV • NASDAQ

Plus Therapeutics Inc

0,29 $

20-yan, 12:58:14 (GMT-5) · USD · NASDAQ · Ogohlantirish

AksiyalarAQSH qimmatli qogʻoziBosh shtabi: AQSH

Yopilish kursi

0,29 $

Kunlik diapazon

0,29 $ - 0,31 $

Yillik diapazon

0,16 $ - 2,31 $

Bozor kapitalizatsiyasi

53,02 mln USD

Oʻrtacha hajm

8,96 mln

Narx/foyda

Dividend daromadliligi

Asosiy maydon

NASDAQ

Bozor yangiliklari

MarketBeat

21 daqiqa oldin

Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Sets New 52-Week High - Should You Buy?

Dow falls by more than 500 points in midday trading, as Treasurys also slide and dollar weakens

Stock Market Is Shifting as S&P 500 Endures Surprising Weakness

Stock market today: Dow, S&P 500, Nasdaq futures sink as Trump tariff threats and bond sell-off rattle nerves

Why Japan’s PM is calling an election three months into office

Forbes

52 daqiqa oldin

S&P 500 Sheds $750 Billion—Greenland’s Estimated Value—On Trump’s Threats, Economist Says

.INX

1,52%

Haqida

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia

Tashkil etilgan

1996

Bosh ofis

Ostin, Texas
Amerika Qo‘shma Shtatlari

Sayt

plustherapeutics.com

Xodimlar soni